1. Home
  2. FLGT vs NMCO Comparison

FLGT vs NMCO Comparison

Compare FLGT & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • NMCO
  • Stock Information
  • Founded
  • FLGT 2011
  • NMCO 2019
  • Country
  • FLGT United States
  • NMCO United States
  • Employees
  • FLGT N/A
  • NMCO N/A
  • Industry
  • FLGT Medical Specialities
  • NMCO Finance/Investors Services
  • Sector
  • FLGT Health Care
  • NMCO Finance
  • Exchange
  • FLGT Nasdaq
  • NMCO Nasdaq
  • Market Cap
  • FLGT 584.9M
  • NMCO 545.8M
  • IPO Year
  • FLGT 2016
  • NMCO N/A
  • Fundamental
  • Price
  • FLGT $20.31
  • NMCO $10.31
  • Analyst Decision
  • FLGT Buy
  • NMCO
  • Analyst Count
  • FLGT 2
  • NMCO 0
  • Target Price
  • FLGT $24.00
  • NMCO N/A
  • AVG Volume (30 Days)
  • FLGT 393.7K
  • NMCO 207.6K
  • Earning Date
  • FLGT 05-02-2025
  • NMCO 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • NMCO 5.43%
  • EPS Growth
  • FLGT N/A
  • NMCO N/A
  • EPS
  • FLGT N/A
  • NMCO N/A
  • Revenue
  • FLGT $292,448,000.00
  • NMCO N/A
  • Revenue This Year
  • FLGT $11.79
  • NMCO N/A
  • Revenue Next Year
  • FLGT $10.45
  • NMCO N/A
  • P/E Ratio
  • FLGT N/A
  • NMCO N/A
  • Revenue Growth
  • FLGT 1.71
  • NMCO N/A
  • 52 Week Low
  • FLGT $14.57
  • NMCO $8.52
  • 52 Week High
  • FLGT $25.11
  • NMCO $11.64
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 56.64
  • NMCO 49.19
  • Support Level
  • FLGT $20.03
  • NMCO $10.10
  • Resistance Level
  • FLGT $21.42
  • NMCO $10.61
  • Average True Range (ATR)
  • FLGT 0.82
  • NMCO 0.19
  • MACD
  • FLGT 0.03
  • NMCO 0.00
  • Stochastic Oscillator
  • FLGT 63.06
  • NMCO 18.64

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About NMCO Nuveen Municipal Credit Opportunities Fund

Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.

Share on Social Networks: